Management of peritoneal carcinomatosis of unknown primary tumor site.
Muggia
F M
FM
Department of Medicine, University of Southern California School of Medicine, Los Angeles.
Baranda
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001201:Ascites / Q000473:pathology; D002277:Carcinoma / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis* / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy
D000970:Antineoplastic Agents